PELLEGRINI, CINZIA

PELLEGRINI, CINZIA  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE  

Risultati 1 - 20 di 66 (tempo di esecuzione: 0.05 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi, Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L 2020-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia; Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi 2016-01-01 CANCER MEDICINE - 1.01 Articolo in rivista cam4.684.pdf
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. 2012-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL 2013-01-01 LEUKEMIA & LYMPHOMA - 1.01 Articolo in rivista -
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Coppola P.E.; Zinzani P.L. 2022-01-01 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY - 1.01 Articolo in rivista Stefoni2022_Article_BEGEVSalvageRegimenInRelapsedR.pdf
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin. Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L 2013-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L. 2020-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience Marangon, Miriam; Tonialini, Lorenzo; Morigi, Alice; Stefoni, Vittorio; Broccoli, Alessandro; Pellegrini, Cinzia; Casadei, Beatrice; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi 2018-01-01 AMERICAN JOURNAL OF HEMATOLOGY - 1.01 Articolo in rivista -
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. 2013-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study Federico, Massimo; Luminari, Stefano; Pellegrini, Cinzia; Merli, Francesco; Pesce, Emanuela Anna; Chauvie, Stephane; Gandolfi, Letizia; Capodanno, Isabella; Salati, Massimiliano; Argnani, Lisa; Zinzani, Pier Luigi 2016-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista e139.full.pdf
Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial Zinzani, Pier Luigi; Pellegrini, Cinzia; Chiappella, Annalisa; Di Rocco, Alice; Salvi, Flavia; Cabras, Maria Giuseppina; Argnani, Lisa; Stefoni, Vittorio 2017-01-01 BLOOD - 1.01 Articolo in rivista -
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gianni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L 2013-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista haematol.2012.083048.full.pdf
Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase 2 study of FIL ONLUS Stefoni, Vittorio; Marangon, Miriam; Re, Alessandro; Lleshi, Arben; Bonfichi, Maurizio; Pinto, Antonello; Bianchetti, Nicola; Pellegrini, Cinzia; Argnani, Lisa; Zinzani, Pier Luigi 2020-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista haematol.2019.243170.full.pdf
Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients Zinzani, Pier Luigi; Pellegrini, Cinzia; Cantonetti, Maria; Re, Alessandro; Pinto, Antonello; Pavone, Vincenzo; Rigacci, Luigi; Celli, Melania; Broccoli, Alessandro; Argnani, Lisa; Pulsoni, Alessandro 2015-01-01 THE ONCOLOGIST - 1.01 Articolo in rivista -
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report Lolli G.; Casadei B.; Argnani L.; Pileri A.; Pellegrini C.; Zinzani P.L. 2021-01-01 ACTA HAEMATOLOGICA - 1.01 Articolo in rivista -
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M. 2011-01-01 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA - 1.01 Articolo in rivista -
Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports. Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL 2013-01-01 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA - 1.01 Articolo in rivista -
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report Lolli G.; Casadei B.; Pellegrini C.; Argnani L.; Cocito F.; Zinzani P.L. 2021-01-01 TUMORI - 1.01 Articolo in rivista -
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Cavo M.; Zinzani P.L. 2020-01-01 CANCER MEDICINE - 1.01 Articolo in rivista cam4.3262.pdf
Efficacy of idelalisib as bridge to allogeneic stem cell transplant in relapsed follicular lymphoma: a case report Marangon, Miriam; Pellegrini, Cinzia; Argnani, Lisa; Zinzani, Pier Luigi 2017-01-01 TUMORI - 1.01 Articolo in rivista -